Search Results - "ORAZI, A"

The myelodysplastic myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features by Orazi, A, Germing, U

“…The 2001 World Health Organization (WHO)-sponsored classification of hematopoietic tumors has, for the first time, clearly defined a group of rare myeloid…”
Get full text

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study by Visco, C, Li, Y, Xu-Monette, Z Y, Miranda, R N, Green, T M, Li, Y, Tzankov, A, Wen, W, Liu, W-m, Kahl, B S, d'Amore, E S G, Montes-Moreno, S, Dybkær, K, Chiu, A, Tam, W, Orazi, A, Zu, Y, Bhagat, G, Winter, J N, Wang, H-Y, O'Neill, S, Dunphy, C H, Hsi, E D, Zhao, X F, Go, R S, Choi, W W L, Zhou, F, Czader, M, Tong, J, Zhao, X, van Krieken, J H, Huang, Q, Ai, W, Etzell, J, Ponzoni, M, Ferreri, A J M, Piris, M A, Møller, M B, Bueso-Ramos, C E, Medeiros, L J, Wu, L, Young, K H

“…Gene expression profiling (GEP) has stratified diffuse large B-cell lymphoma (DLBCL) into molecular subgroups that correspond to different stages of lymphocyte…”
Get full text

Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes by Della Porta, M G, Travaglino, E, Boveri, E, Ponzoni, M, Malcovati, L, Papaemmanuil, E, Rigolin, G M, Pascutto, C, Croci, G, Gianelli, U, Milani, R, Ambaglio, I, Elena, C, Ubezio, M, Da Via’, M C, Bono, E, Pietra, D, Quaglia, F, Bastia, R, Ferretti, V, Cuneo, A, Morra, E, Campbell, P J, Orazi, A, Invernizzi, R, Cazzola, M

“…The World Health Organization classification of myelodysplastic syndromes (MDS) is based on morphological evaluation of marrow dysplasia. We performed a…”
Get full text

Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the international working group for myelofibrosis research and treatment by Barosi, G, Mesa, R A, Thiele, J, Cervantes, F, Campbell, P J, Verstovsek, S, Dupriez, B, Levine, R L, Passamonti, F, Gotlib, J, Reilly, J T, Vannucchi, A M, Hanson, C A, Solberg, L A, Orazi, A, Tefferi, A

Get full text

Myeloproliferative neoplasms (BCR-ABL1 negative) and myelodysplastic/myeloproliferative neoplasms: current diagnostic principles and upcoming updates by Geyer, J. T., Orazi, A.

“…Summary Since the publication of the latest World Health Organization (WHO) classification in 2008, there has been a significant effort for clarification of…”
Get full text

Diagnostic criteria to distinguish hypocellular acute myeloid leukemia from hypocellular myelodysplastic syndromes and aplastic anemia: recommendations for a standardized approach by Bennett, John M, Orazi, Attilio

“…1 James P. Wilmot Cancer Center, University of Rochester Medical Center, Department of Pathology and Laboratory Medicine, Rochester, NY 2 Weill Medical College…”
Get full text

EAHP 2020 workshop proceedings, pediatric myeloid neoplasms by Leguit, R. J., Orazi, A., Kucine, N., Kvasnicka, H. M., Gianelli, U., Arber, D. A., Porwit, A., Ponzoni, M.

“…The first section of the bone marrow workshop of the European Association of Haematopathology (EAHP) 2020 Virtual Meeting was dedicated to pediatric myeloid…”
Get full text

Myelodysplastic/myeloproliferative neoplasms: are morphology and immunophenotyping still relevant? by Sangiorgio, V.F.I., Orazi, A., Arber, D.A.

“…The term myelodysplastic/myeloproliferative neoplasm (MDS/MPN) refers to a group of clonal hematopoietic neoplasms with overlapping clinical, morphologic and…”
Get full text

Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma by Xia, Y, Xu-Monette, Z Y, Tzankov, A, Li, X, Manyam, G C, Murty, V, Bhagat, G, Zhang, S, Pasqualucci, L, Visco, C, Dybkaer, K, Chiu, A, Orazi, A, Zu, Y, Richards, K L, Hsi, E D, Choi, W W L, van Krieken, J H, Huh, J, Ponzoni, M, Ferreri, A J M, Møller, M B, Parsons, B M, Winter, J N, Piris, M A, Westin, J, Fowler, N, Miranda, R N, Ok, C Y, Li, Y, Li, J, Medeiros, L J, Young, K H

“…PRDM1 /BLIMP-1, a master regulator of plasma-cell differentiation, is frequently inactivated in activated B-cell-like (ABC) diffuse large B-cell lymphoma…”
Get full text

Myelodysplastic syndrome transforming to atypical chronic myeloid leukemia shows changes in its mutation allele frequency and acquisition of new mutations by NM, Hakim, W, Tam, A, Philipovskiy, V, Tonk, A, Orazi

“…Although acute transformation to acute myeloid leukemia represents a well-established form of disease progression in myelodysplastic syndromes (MDS), the…”
Get full text

Quantification of marrow CD34+ cells: an important tool for distinguishing between hypoplastic myelodysplastic syndromes and aplastic anemia by Orazi, A

Get full text

Reply to Matsui et al by Orazi, A

Get full text

Hypermethylation of the tumor suppressor gene PRDM1/Blimp-1 supports a pathogenetic role in EBV-positive Burkitt lymphoma by Zhang, T, Ma, J, Nie, K, Yan, J, Liu, Y, Bacchi, C E, Queiroga, E M, Gualco, G, Sample, J T, Orazi, A, Knowles, D M, Tam, W

“…PRDM1/Blimp-1 is a tumor suppressor gene in the activated B-cell subtype of diffuse large B-cell lymphomas. Its inactivation contributes to pathogenesis in…”
Get full text

Addition of rituximab to chemotherapy overcomes the negative prognostic impact of cyclin E expression in diffuse large B-cell lymphoma by Frei, E, Visco, C, Xu-Monette, Z Y, Dirnhofer, S, Dybkær, K, Orazi, A, Bhagat, G, Hsi, E D, van Krieken, J H, Ponzoni, M, Go, R S, Piris, M A, Møller, M B, Young, K H, Tzankov, A

“…High levels of cyclin E (CCNE) are accompanied by shorter survival in cyclophosphamide, hydroxydaunorubicin, oncovin and prednisone (CHOP)-treated diffuse…”
Get more information

Inactivation of BANK1 in a novel IGH-associated translocation t(4;14)(q24;q32) suggests a tumor suppressor role in B-cell lymphoma by Yan, J, Nie, K, Mathew, S, Tam, Y, Cheng, S, Knowles, D M, Orazi, A, Tam, W

Get full text

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study by Visco, C, Li, Y, Xu-Monette, Z.Y, Miranda, R.N, Green, T.M, Tzankov, A, Wen, W, Liu, W-m, Kahl, B.S, d'Amore, E.S.G, Montes-Moreno, S, Dybkaer, K, Chiu, A, Tam, W, Orazi, A, Zu, Y, Bhagat, G, Winter, J.N, Wang, H.-Y, O'Neill, S, Dunphy, C.H, Hsi, E.D, Zhao, X.F, Go, R.S, Choi, W.W.L, Zhou, F, Czader, M, Tong, J, Zhao, X, van Krieken, J.H, Huang, Q, Ai, W, Etzell, J, Ponzoni, M, Ferreri, A.J.M, Piris, M.A, Moller, M.B, Bueso-Ramos, C.E, Medeiros, L.J, Wu, L, Young, K.H

Get full text

Clonal X-chromosome inactivation suggests that splenic cord capillary hemangioma is a true neoplasm and not a subtype of splenic hamartoma by Chiu, A, Czader, M, Cheng, L, Hasserjian, R P, Wang, M, Bhagavathi, S, Hyjek, E M, Al-Ahmadie, H, Knowles, D M, Orazi, A

“…Splenic hamartoma is a rare tumor-like lesion composed of structurally disorganized red pulp elements. It has been hypothesized that two other splenic lesions,…”
Get full text

Retroviral vector integration in post-transplant hematopoiesis in mice conditioned with either submyeloablative or ablative irradiation by Sadat, M A, Dirscherl, S, Sastry, L, Dantzer, J, Pech, N, Griffin, S, Hawkins, T, Zhao, Y, Barese, C N, Cross, S, Orazi, A, An, C, Goebel, W S, Yoder, M C, Li, X, Grez, M, Cornetta, K, Mooney, S D, Dinauer, M C

“…X-linked chronic granulomatous disease (X-CGD) is an inherited immunodeficiency with absent phagocyte NADPH-oxidase activity caused by defects in the…”
Get full text

A Bone Marrow Stromal-Derived Growth Factor, Interleukin-11, Stimulates Recovery of Small Intestinal Mucosal Cells After Cytoablative Therapy by Du, X.X., Doerschuk, C.M., Orazi, A., Williams, D.A.

“…The proliferation of epithelial cells lining the small intestinal mucosa may be regulated by microenvironmental signals leading to differentiation of precursor…”
Get full text

Protective effects of interleukin-11 in a murine model of ischemic bowel necrosis by Du, X, Liu, Q, Yang, Z, Orazi, A, Rescorla, F J, Grosfeld, J L, Williams, D A

“…The present study examined the effect of interleukin-11 (IL-11) in a murine model of bowel ischemia (BI). Prophylactic IL-11 administration in BI mice (induced…”
Get full text